Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi's Dupixent falls short in phase 3 chronic spontaneous urticaria trial
Pharmaforum
Fri, 02/18/22 - 10:40 am
Tags:
Sanofi, Regeneron, clinical trials, Dupixent, chronic spontaneous urticaria
Innovent's phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market
Fierce Biotech
Thu, 02/17/22 - 10:56 am
Tags:
Innovent Biologics, China, clinical trials, Amgen, Sanofi
Sanofi's simplified brand opens a fresh chapter as new strategy, pandemic help turn the page
Fierce Pharma
Mon, 02/7/22 - 11:22 am
Tags:
Sanofi, branding, corporate branding
FDA approves Sanofi's monoclonal antibody treatment for CAD
Biopharma Reporter
Mon, 02/7/22 - 10:29 am
Tags:
Sanofi, cold agglutinin disease, FDA, monoclonal antibodies, Enjaymo
Sanofi's Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter
Fierce Pharma
Fri, 02/4/22 - 01:06 pm
Tags:
Sanofi, Dupixent, earnings, COVID-19
Eleven years after buying Genzyme, Sanofi officially ditches subsidiary’s storied name
Boston Globe, MA
Thu, 02/3/22 - 11:39 am
Tags:
Sanofi, branding, corporate branding, Genzyme
Regeneron and Sanofi pull Libtayo app in cervical cancer, citing post-market study disagreement with FDA
Endpoints
Sun, 01/30/22 - 11:42 am
Tags:
Sanofi, Regeneron, Libtayo, cervical cancer, post-marketing studies
Sanofi claims high-rises neighboring its Toronto facility would pose 'national security' threat
Endpoints
Wed, 01/26/22 - 10:54 am
Tags:
Sanofi, Canada, Toronto
The top 10 biopharma M&A deals in 2021
Fierce Pharma
Tue, 01/18/22 - 10:53 am
Tags:
M&A, CSL, Vifor, Jazz Pharmaeuticals, GW Pharma, Novo Nordisk, Dicerna, Horizon Therapeutics, Viela Bio, Perrigo, HRA Pharma, Sanofi, Kadmon, Merck, Acceleron, Pfizer, Arena Pharmaceuticals, Translate Bio, Trillium Therapeutics, Amgen, Five Prime Therapeutics
Pfizer's Cibinqo snags FDA approval to challenge Sanofi and Regeneron's Dupixent in eczema
Fierce Pharma
Sun, 01/16/22 - 03:53 am
Tags:
Pfizer, Sanofi, Regeneron, FDA, Cibinqo, atopic dermatitis
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
Tags:
M&A, biotech, Amylyx Pharmaceuticals, Arena Pharmaceuticals, AstraZeneca, Aurinia Pharmaceuticals, Biogen, Biohaven, Bristol Myers Squibb, Eli Lilly, GSK, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi
JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn't plan to stop there, exec says
Fierce Pharma
Thu, 01/13/22 - 11:06 am
Tags:
JPMHC 2022, Novartis, Leqvio, drug launches, Regeneron, Amgen, Sanofi
Sanofi makes $75M preclinical bet to join Roche, Novartis and more in congested Parkinson's field
Fierce Biotech
Wed, 01/12/22 - 11:19 pm
Tags:
Sanofi, ABL Bio, Parkinson's Disease, ABL301
JPM 2022: Sanofi has designs on creating Big Pharma's 'strongest' immunology franchise, CFO says
Fierce Pharma
Tue, 01/11/22 - 10:18 pm
Tags:
Sanofi, JPMHC 2022, M&A, Paul Hudson
JPM22, Day 2: Sanofi's dealmaking priorities, bluebird's gene therapy goals and more
Fierce Pharma
Tue, 01/11/22 - 11:37 am
Tags:
JPMHC 2022, GSK, Sanofi, Bluebird Bio
Sanofi makes AI play, putting up $100M and billions in biobucks to form broad deal with Exscientia
Fierce Biotech
Fri, 01/7/22 - 10:37 am
Tags:
Sanofi, R&D, artificial intelligence, Exscientia
Sanofi cuts ties with Sangamo, sharpening focus on 'off-the-shelf' cell therapy
BioPharma Dive
Thu, 01/6/22 - 12:39 pm
Tags:
Sanofi, Sangamo Therapeutics, cell therapy, sickle cell disease
10 clinical trials to watch in the first half of 2022
BioPharma Dive
Mon, 01/3/22 - 10:46 am
Tags:
clinical trials, Pfizer, Arena Pharmaceuticals, etrasimod, Sanofi, GSK, vaccines, COVID-19, Roche, gantenerumab, AbbVie, Gilead Sciences, Trodelvy, Karuna Therapeutics, KarXT, Intercept Pharma, obeticholic acid, Allogene, ALLO-501a
Leo puts target on Dupixent in US as FDA clears tralokinumab
Pharmaforum
Thu, 12/30/21 - 10:45 am
Tags:
Sanofi, Regeneron, Dupixent, tralokinumab, FDA
2022 forecast: Will biopharma's offices ever go back to 'normal'? Sanofi, Novartis and more chime in
Fierce Pharma
Wed, 12/22/21 - 11:37 pm
Tags:
COVID-19, pandemic, remote work, Sanofi, Biogen, Pfizer, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.